Product Information
ETODOLAC 400 MG TABLET is a generic product labeled by Chartwell RX LLC, priced at $0.2624 per EA under NDC 62135091060. Its NADAC has been published 92 times since Jan 1, 2025.
FDA first approved this application on Nov 30, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
400 mg/1
Manufacturer
Chartwell RX LLCNDC
62135091060
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ETODOLACApproval Type
Generic (ANDA)
FDA Application
ANDA209888FDA Approved
11/30/2018
TE Code
AB
On Market Since
12/7/2018
Pharmacological Classes
Price Statistics
The NADAC for ETODOLAC 400 MG TABLET has been published 92 times since Jan 1, 2025, and over the history we have for it it has risen 8.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2624 per EA |
|---|---|
| All-time high | $0.2694 (Jun 10, 2026) |
| All-time low | $0.2419 (Jan 1, 2025) |
| 52-week high | $0.2694 |
| 52-week low | $0.2463 |
| Median price | $0.2572 |
| Average price | $0.2567 |
| Largest weekly change | +5.6% (Feb 19, 2025) |
| Weeks tracked | 92 |
| Tracking since | Jan 1, 2025 |
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chartwell RX LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Etodolac market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ETODOLAC 400 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ETODOLAC 400 MG TABLET, manufactured by Chartwell RX LLC, is $0.2624 per EA (NDC 62135091060), effective Sep 30, 2026.
How has the price of ETODOLAC 400 MG TABLET changed over time?
Over the history we have for it, the NADAC for ETODOLAC 400 MG TABLET has risen 8.5%. It has been tracked across 92 weekly CMS publications since Jan 1, 2025.
What are the highest and lowest recorded NADAC prices for ETODOLAC 400 MG TABLET?
Since Jan 1, 2025, the NADAC for ETODOLAC 400 MG TABLET has ranged from a low of $0.2419 (Jan 1, 2025) to a high of $0.2694 (Jun 10, 2026), with a median of $0.2572 per EA.
Are there cheaper alternatives to ETODOLAC 400 MG TABLET?
8 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ETODOLAC 400 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures ETODOLAC 400 MG TABLET?
ETODOLAC 400 MG TABLET (NDC 62135091060) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.